Ginkgo Bioworks Holdings Inc (NYSE:DNA)
$ 7.99 0.36 (4.72%) Market Cap: 444.05 Mil Enterprise Value: 145.94 Mil PE Ratio: 0 PB Ratio: 0.50 GF Score: 39/100

Q3 2021 Ginkgo Bioworks Holdings Inc Earnings Call Transcript

Nov 15, 2021 / 01:00PM GMT
Anna Marie Wagner

Good morning, everyone. This is Anna Marie Wagner, I'm the SVP of Corporate Development at Ginkgo. I'm joined today by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO. We're honored that you chose to start your week with us, and we're looking forward to updating you on our tremendous progress so far this year.

Needless to say, it's been an exciting quarter. And to help warm up the crowd, I just wanted to remind you that during the presentation today, we'll be making forward-looking statements. Those involve risks and uncertainties, so please refer to our filings with the Securities and Exchange Commission to learn more about those risks and uncertainties.

During our quarterly earnings call, we will, of course, be updating you on our financial progress. But we also want to use these opportunities to continue to build a deeper understanding of what we're doing at Ginkgo. And so after our financial updates, we'll always feature a strategic deep dive each quarter, which today will be led by Jason. If there are topics you'd like to see in a future deep dive, please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot